Your browser doesn't support javascript.
loading
Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology.
Bristow, Robert G; Alexander, Brian; Baumann, Michael; Bratman, Scott V; Brown, J Martin; Camphausen, Kevin; Choyke, Peter; Citrin, Deborah; Contessa, Joseph N; Dicker, Adam; Kirsch, David G; Krause, Mechthild; Le, Quynh-Thu; Milosevic, Michael; Morris, Zachary S; Sarkaria, Jann N; Sondel, Paul M; Tran, Phuoc T; Wilson, George D; Willers, Henning; Wong, Rebecca K S; Harari, Paul M.
Afiliación
  • Bristow RG; Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON, Canada. Electronic address: robert.bristow@manchester.ac.uk.
  • Alexander B; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Baumann M; OncoRay, Dresden, Germany.
  • Bratman SV; Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Brown JM; Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
  • Camphausen K; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Choyke P; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Citrin D; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Contessa JN; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA.
  • Dicker A; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
  • Kirsch DG; Department of Radiation Oncology and Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA.
  • Krause M; OncoRay, Dresden, Germany.
  • Le QT; Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
  • Milosevic M; Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Morris ZS; Department of Human Oncology, University of Wisconsin, Madison, WI, USA.
  • Sarkaria JN; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
  • Sondel PM; Department of Human Oncology, University of Wisconsin, Madison, WI, USA.
  • Tran PT; Department of Radiation Oncology and Molecular Radiation Sciences, Department of Oncology, and Department of Urology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Wilson GD; Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, USA.
  • Willers H; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Wong RKS; Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Harari PM; Department of Human Oncology, University of Wisconsin, Madison, WI, USA.
Lancet Oncol ; 19(5): e240-e251, 2018 05.
Article en En | MEDLINE | ID: mdl-29726389
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Oncología por Radiación / Medicina de Precisión / Terapia Molecular Dirigida / Quimioradioterapia / Factores Inmunológicos / Inmunoterapia / Neoplasias / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Oncología por Radiación / Medicina de Precisión / Terapia Molecular Dirigida / Quimioradioterapia / Factores Inmunológicos / Inmunoterapia / Neoplasias / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article